학술논문
Fludarabine, Arabinosyl Cytosine and Idarubicin (FLAI) for Remission Induction in Poor-Risk Acute Myeloid Leukemia.
Document Type
Article
Author
Source
Subject
*ACUTE myeloid leukemia
*COMBINATION drug therapy
*DRUG therapy
*DRUG efficacy
*
*
*
Language
ISSN
1042-8194
Abstract
Documents the effectiveness of combination fludarabine, arabinosyl cytosine and idarubicin (FLAI) regimen in poor-risk acute myeloid leukemia patients. Complete remission rate; Projected 2-year and relapse-free survival; Mean time to hematologic recovery; Mobilization of peripheral blood stem cells.